Profiel
Mikio Kawahara currently works at AccuRna, Inc., as Director from 2017, Braizon Therapeutics, Inc., as Outside Director from 2018, Adriakaim, Inc., as Outside Director from 2020, Fimecs, Inc., as Outside Director from 2020, and UTokyo Innovation Platform Co.,Ltd., as Partner and Chief Investment Officer from 2016.
Actieve functies van Mikio Kawahara
| Bedrijven | Functie | Begin |
|---|---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Directeur/Bestuurslid | 01-12-2017 |
Fimecs, Inc.
Fimecs, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of new drugs whose mechanism is induction of proteolysis | Directeur/Bestuurslid | 01-01-2020 |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo IPC is an active manger which targets companies of University of Tokyo origin. It provides equity for pre-seed, seed and early-stages capital requirements. | Chief Investment Officer | 01-01-2016 |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Directeur/Bestuurslid | 01-08-2018 |
Adriakaim, Inc.
Adriakaim, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical and health-related equipment & provides management and technology strategy consulting services | Directeur/Bestuurslid | 01-05-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Health Technology |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo IPC is an active manger which targets companies of University of Tokyo origin. It provides equity for pre-seed, seed and early-stages capital requirements. | Finance |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Commercial Services |
Adriakaim, Inc.
Adriakaim, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical and health-related equipment & provides management and technology strategy consulting services | Health Technology |
Fimecs, Inc.
Fimecs, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of new drugs whose mechanism is induction of proteolysis | Commercial Services |
















